Selective Alanine Transporter Utilization is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer

Download PDF

"*" indicates required fields

Comments

This field is for validation purposes and should be left unchanged.

Salutation*

First Name*

Last Name*

Email*

Country/Region*

Institution/Company*

Industry*

Position*

Research area*

Organ*

Stage of research*

Does your laboratory perform stainings on tissue samples?*

Terms and condtions*

I acknowledge and agree to the terms laid out in the Terms and Conditions and Privacy Policy on our website.

Communications consent

I agree to receive relevant marketing communications from Bio-Techne and its brands in accordance with Bio-Techne’s Privacy Policy.

CAPTCHA

Tolochenaz, Switzerland

[email protected]

COMET™ is CE/UKCA/UL marked and is For Research Use Only.
Not for use in diagnostic procedures.